Génomic Vision SAのEPS 1株当たり利益
Génomic Vision SAのEPS 1株当たり利益 は何ですか。
Génomic Vision SAのEPS 1株当たり利益 は-0.10です。
EPS 1株当たり利益 の定義は何ですか。
1株当たり利益（EPS) は、当社の1株当たり利益です。それは株式の希釈を考慮に入れ、 過去12ヶ月間にカウントされます。
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EURONEXTのセクタHealth CareにおけるEPS 1株当たり利益 の企業と比べるGénomic Vision SA
Génomic Vision SAは何をしますか。
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Génomic Vision SAと類似のeps 1株当たり利益
- Mirasol ResourcesのEPS 1株当たり利益 は-0.10です。
- Kovo HealthTechのEPS 1株当たり利益 は-0.10です。
- Silver Bull ResourcesのEPS 1株当たり利益 は-0.10です。
- Sandfire ResourcesのEPS 1株当たり利益 は-0.10です。
- Winshine ScienceのEPS 1株当たり利益 は-0.10です。
- FRNTのEPS 1株当たり利益 は-0.10です。
- Génomic Vision SAのEPS 1株当たり利益 は-0.10です。
- Barings Global Short Duration High Yield FundのEPS 1株当たり利益 は-0.10です。
- Numinus WellnessのEPS 1株当たり利益 は-0.10です。
- NuchevのEPS 1株当たり利益 は-0.10です。
- Goodman Stapled SecuritiesのEPS 1株当たり利益 は-0.10です。
- Umiya TubesのEPS 1株当たり利益 は-0.10です。
- Auxly CannabisのEPS 1株当たり利益 は-0.10です。